Does Dr. Baiju study polycystic ovarian syndrome?

Yes, Dr. Baiju focuses on polycystic ovarian syndrome and its impact on fertility.

What treatments has Dr. Baiju researched?

He has researched the effects of hormone treatments, particularly gonadotropin-releasing hormone agonists, on improving IVF outcomes.

Is Dr. Baiju's work relevant to women facing infertility?

Yes, his research aims to provide better treatment options for women facing infertility, especially those with PCOS.

DR. PRADIP B. BAIJU, M.D.

ORLANDO, FL

Research Active

Internal Medicine - Interventional Cardiology NPI registered 21+ years 1 publication 2017 – 2017 NPI: 1831192186

Internal Medicine - Interventional Cardiology Internal Medicine - Cardiovascular Disease

Practice Location

1277 N SEMORAN BLVD
ORLANDO, FL 32807-3569

Phone: (407) 730-8970

What does PRADIP BAIJU research?

Dr. Baiju studies infertility issues, especially in women with polycystic ovarian syndrome, a condition that can disrupt normal ovulation and make it difficult to conceive. He examines how different hormone treatments affect the success of IVF procedures, which help women become pregnant. One of his key focuses is on the use of gonadotropin-releasing hormone agonists, a type of hormone therapy, to potentially improve egg production and pregnancy rates during these fertility treatments.

Key findings

Women who received a repeat dose of the gonadotropin-releasing hormone agonist produced an average of 4 mature eggs, compared to 3 eggs with just one dose.
The group that received the repeat hormone trigger had higher chances of pregnancy during IVF treatments due to improved egg production.
This study indicates that a specific treatment approach could enhance the chances of conception for women with PCOS undergoing fertility treatments.

Frequently asked questions

Does Dr. Baiju study polycystic ovarian syndrome?: Yes, Dr. Baiju focuses on polycystic ovarian syndrome and its impact on fertility.
What treatments has Dr. Baiju researched?: He has researched the effects of hormone treatments, particularly gonadotropin-releasing hormone agonists, on improving IVF outcomes.
Is Dr. Baiju's work relevant to women facing infertility?: Yes, his research aims to provide better treatment options for women facing infertility, especially those with PCOS.

Publications in plain English

Repeat Dose of Gonadotropin-releasing Hormone Agonist Trigger in Polycystic Ovarian Syndrome UndergoingFertilization Cycles Provides a Better Cycle Outcome - A proof-of-concept Study.

2017

Journal of human reproductive sciences

Deepika K, Baiju P, Gautham P, Suvarna R, Arveen V +1 more

Plain English
This study looked at how giving a second dose of a hormone trigger (gonadotropin-releasing hormone agonist, or GnRHa) affects the outcome of in-vitro fertilization (IVF) in women with polycystic ovarian syndrome (PCOS). Researchers found that patients who received a repeat dose produced an average of 4 mature eggs compared to 3 from those who only received one dose, and they had better chances of becoming pregnant. This matters because it suggests that a specific treatment approach could improve IVF success for women with PCOS. Who this helps: Patients facing challenges with infertility due to PCOS.

PubMed

Frequent Co-Authors

Krishna Deepika Praneesh Gautham Rathore Suvarna Vohra Arveen Rao Kamini

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.